1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsImproving Menstrual Health Among Women and Girls Using Community Engaged Intervention Development in Nepal is sponsored by Fogarty International Center at the National Institutes of Health (NIH). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Improving Menstrual Health Among Women and Girls Using Community Engaged Intervention Development in Nepal - Fogarty International Center @ NIH NIH Websites Are Changing Get the Latest Updates and FAQs Improving Menstrual Health Among Women and Girls Using Community Engaged Intervention Development in Nepal Search and filter all Fogarty grants Search all NIH grants and grantees using NIH RePORTER The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).
International Research Scientist Development Award (IRSDA) Project Information in NIH RePORTER Improving Menstrual Health Among Women and Girls Using Community Engaged Intervention Development in Nepal University of Pittsburgh at Pittsburgh Principal Investigator(s) (PI) Project Contact Information Harmful menstrual practices, such as chhaupadi (menstrual seclusion) in Nepal, are an urgent threat to women’s health, well-being, and development.
This study will investigate underlying mechanisms of promising aspects of chhaupadi interventions to date and build upon these findings to co-design and pilot test a context- specific intervention in partnership with community members.
In the short-term, outcomes from this proposal will advance the field by resulting in: a pilot-tested intervention that can be further tested in a future randomized controlled trial; a refined approach for engaging communities in sustainable and contextually appropriate intervention co-design that is expected to be applicable to other low- and middle-income country contexts; and in the longer-term, support public health efforts aiming to reduce the negative health effects of harmful menstrual practices on women in Nepal.
Related World Regions / Countries
According to the current listing, eligibility includes: Non-U. S. organizations, including those in Nepal, are eligible to apply. Confirm the full requirements in the official notice before applying.
Improving Menstrual Health Among Women and Girls Using Community Engaged Intervention Development in Nepal is funded by Fogarty International Center at the National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article